Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
miniSTONE-1: Baloxavir Marboxil in Infants <1 Year
NCT03653364Phase 3Completed
- Sponsor
- Roche
- Start
- Jan 2019
- Primary completion
- Apr 2023
- Modality
- Small Molecules
- Countries
- 9
01
Overview
Phase 3, open-label, single-arm trial of baloxavir marboxil in influenza, sponsored by Roche. Primary endpoint: Number of Participants With Adverse Events (AEs) and Serious Adverse Events (SAEs). Started Jan 2019; status: completed.
02
Drugs
baloxavir marboxil
03
Conditions
influenza
Beyond the preview
Go deeper on NCT03653364.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03653364.